Brighton Jones LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,937 shares of the healthcare conglomerate’s stock, valued at approximately $545,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Marshall Wace LLP lifted its position in UnitedHealth Group by 441.4% during the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after purchasing an additional 11,361 shares during the period. Schwab Charles Investment Management Inc. lifted its position in UnitedHealth Group by 5.3% during the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after purchasing an additional 183,401 shares during the period. American Century Companies Inc. lifted its position in UnitedHealth Group by 16.9% during the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after purchasing an additional 681,111 shares during the period. Suntrust Banks Inc. lifted its position in UnitedHealth Group by 8.5% during the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock worth $42,774,000 after purchasing an additional 20,541 shares during the period. Finally, Essex Financial Services Inc. lifted its position in UnitedHealth Group by 12.3% during the second quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after purchasing an additional 967 shares during the period. 86.14% of the stock is owned by institutional investors and hedge funds.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the sale, the director now owns 60,834 shares in the company, valued at $12,135,774.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders sold 72,149 shares of company stock valued at $14,212,342 in the last quarter. Corporate insiders own 0.89% of the company’s stock.

UNH has been the subject of several recent analyst reports. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, October 10th. ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein reissued an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a report on Monday, July 10th. Deutsche Bank AG increased their target price on shares of UnitedHealth Group from $187.00 to $197.00 and gave the stock a “buy” rating in a report on Thursday, July 13th. Finally, Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $205.00 target price (up previously from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Three investment analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $215.27.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter in the previous year, the company posted $2.17 earnings per share. The business’s revenue was up 8.7% on a year-over-year basis.

ILLEGAL ACTIVITY NOTICE: This article was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this article on another website, it was illegally stolen and republished in violation of international copyright and trademark laws. The legal version of this article can be read at https://theolympiareport.com/2017/11/02/brighton-jones-llc-acquires-new-stake-in-unitedhealth-group-incorporated-unh.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.